InMode Ltd. (NASDAQ:INMD) Receives Consensus Recommendation of “Hold” from Brokerages

InMode Ltd. (NASDAQ:INMD) has been given a consensus recommendation of “Hold” by the eight brokerages that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $16.00.

Several analysts have issued reports on the stock. Barclays set a $19.00 target price on shares of InMode and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Robert W. Baird reduced their price target on shares of InMode from $17.00 to $14.00 and set a “neutral” rating for the company in a research report on Thursday, May 7th.

InMode Price Performance

Shares of INMD opened at $14.80 on Friday. InMode has a twelve month low of $12.72 and a twelve month high of $16.74. The stock has a market cap of $850.70 million, a PE ratio of 10.88 and a beta of 1.91. The business’s 50-day moving average price is $13.94 and its 200-day moving average price is $14.15.

InMode (NASDAQ:INMD) last released its quarterly earnings data on Wednesday, May 6th. The healthcare company reported $0.25 EPS for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.05). The firm had revenue of $82.02 million during the quarter, compared to the consensus estimate of $79.84 million. InMode had a net margin of 23.27% and a return on equity of 13.47%. InMode’s revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.31 earnings per share.

Hedge Funds Weigh In On InMode

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Deutsche Bank AG increased its stake in InMode by 35.9% in the 4th quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company’s stock worth $58,000 after acquiring an additional 1,037 shares during the last quarter. Quadrant Capital Group LLC boosted its position in shares of InMode by 127.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company’s stock valued at $29,000 after acquiring an additional 1,091 shares during the last quarter. Inspire Investing LLC grew its holdings in shares of InMode by 6.1% during the first quarter. Inspire Investing LLC now owns 19,366 shares of the healthcare company’s stock worth $265,000 after purchasing an additional 1,111 shares in the last quarter. Leonteq Securities AG bought a new position in shares of InMode in the fourth quarter worth approximately $26,000. Finally, Plan A Wealth LLC increased its position in shares of InMode by 16.2% in the fourth quarter. Plan A Wealth LLC now owns 12,878 shares of the healthcare company’s stock worth $189,000 after purchasing an additional 1,793 shares during the last quarter. 68.04% of the stock is currently owned by hedge funds and other institutional investors.

InMode Company Profile

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.